Document:

CURRENT CAPITAL CORP.
                            Suite 200, 47 Avenue Rd.
                               Toronto, ON M5R 2G3
                  Tel. 416-860-0211 | Toll-Free: 1-877-859-5200
                   Fax: 416-361-6228 | www.currentcapital.com
                                                                October 18, 2004

Dermisonics,  Inc.,
Four  Tower  Bridge,
200  Bar-Harbor  Drive,
West  Conshohoken,  PA
19428-2977

Dear  Sirs:

                        RE:  INVESTOR RELATIONS CONTRACT

This  letter  confirms  the  terms  of  the  agreement  ("Agreement")  between
Dermisonics, Inc. (the "Corporation") and Current Capital Corp., ("CCC").

1.  RECITALS.  The  Corporation  has  agreed  to  engage  CCC  as an independent
contractor  and  consultant  to  provide  investor  relation  services  to  the
Corporation,  and  CCC  has agreed to provide these services to the Corporation,
subject  to  the  terms  and  conditions  described  in  this  letter.

2.  TERM.  The  initial term of the engagement is for a period of 12 months from
the  date  of  this  letter.  This  agreement  may  be renewed at the end of the
initial  term  for  an  additional 12 months, with the same terms and conditions
subject  to both parties' agreement.  This agreement may be canceled on 30 days'
written  notice  by  the  Corporation.

3.  SERVICES.  CCC  will  provide  to  the  Corporation  the following services:

RETAIL  COMMUNICATIONS
-    Corporate introduction to select Canadian and US investor networks
-    Investor presentations
-    Ongoing inbound/outbound correspondence and email communications

BROKER  COMMUNICATIONS
-    Corporate introduction to select Canadian and US broker networks
-    Ongoing inbound/outbound correspondence and email communications
-    Coordination of brokerage conferences and/or meetings

SHAREHOLDER  CONVERSION/IDENTIFICATION  PROGRAM
-    Outbound correspondence and email communications for lead generation
     programs
-    Introduction and ongoing communications support for existing shareholder
     base

INSTITUTIONAL  COMMUNICATIONS
-    Corporate introduction to Canadian and US institutions and fund managers
-    Inbound/outbound correspondence and email communications

ANALYST  COMMUNICATIONS
-    Corporate introduction to Canadian and US institutions and fund managers
-    Inbound/outbound correspondence and email communications

                                     Page 1
<PAGE>
-    Analyst field trips

In  addition,  CCC  will  provide the Corporation with a premium position on its
homepage  (standard sized "Client Information Board" banner on the corporate web
site  at  http://www.currentcapital.com  at  no  additional  cost).

CCC  will  also  distribute  to  the  subscribers  of  the  Current Capital News
newsletter,  all  corporate  announcements  and  earnings  announcements  of the
Corporation,  at  no  extra  cost.

4. COSTS. The Corporation will be responsible for all printing and distribution,
press  release  and/or  advertising costs recommended by CCC and approved by the
Corporation.  The  Corporation  will  also be responsible for all travel related
costs  incurred  by  CCC  when providing its' services as determined by CCC when
pre-approved  and  prepaid  by  the  Corporation.

5.  Compensation  for  Services.

a)  During  the term of this agreement the Corporation will pay CCC USD1,250 per
month,  plus  applicable  taxes, payable in advance.  Monthly payments hereunder
will  commence  on November 15, 2004 and continue to be made on the 15th of each
month  thereafter  during  the  term  of  this  agreement.

b)  The  Corporation will grant to CCC options to purchase 200,000 common shares
of  the  Corporation  at  a price of $2 per share, which options shall be deemed
vested  as  of  the  date  of  this agreement.  Such optioned shares shall enjoy
"piggyback"  registration  rights  and  shall  be  registered  in  the  first
registration  statement  filed  by  the Corporation with the U.S. Securities and
Exchange Commission. The options granted to CCC will enable CCC to purchase such
shares  at  anytime  commencing  from  the date of engagement for a period of 12
months  at  the  above  stated  price.  The  Corporation will make all necessary
registrations  and/or  compliances  with  the  U.S.  Securities  and  Exchange
Commission  ("SEC") in accordance with the options defined herein.   This Option
may  be  exercised  in  full  or  in part or not at all by CCC by payment to the
Corporation  at  its  principal  office,  accompanied by payment, in cash, or by
certified  or  official  bank cheque payable to the order of the company, in the
amount  obtained  by  multiplying  (i)  the  number  of  shares  of common stock
designated  by  the  holder  by  (ii)  the  Purchase  Price.

6.  CONFIDENTIALITY.  CCC,  and  any  of  its  employees,  agents,  consultants,
representatives and advisors, will keep secret and confidential, all information
disclosed  to  it  by  the  Corporation  or  developed  by  CCC in the course of
providing  and  performing  services,  except:

a)   Information which at the time of disclosure is in the public domain;

b)  Information  which, after disclosure, is published or otherwise becomes part
of  the public domain through no fault of CCC (but only after it is published or
otherwise  becomes  part  of  the  public  domain);

c)  Information  which  CCC  can  show was in its possession prior to disclosure
hereunder;

d)  Information  which  CCC  can  show  was  received  by  it, after the time of
disclosure  hereunder,  from  a  third  party  who did not require to hold it in
confidence  and  who  did  not,  to  their  knowledge,  acquire  it, directly or
indirectly,  from  CCC  or  a  third party under an obligation of confidence; or

e)  Information  which  CCC is legally compelled to disclose under a subpoena or
order  of a court, regulatory body or other authority of competent jurisdiction,
or  information  which  it  is  otherwise  obliged  to  disclose  by  law.

                                     Page 2
<PAGE>
7.  ADDITIONAL  OBLIGATIONS  OF  CCC.  CCC  agrees  that, in connection with its
investor  relation  services  to the Corporation, it will abide by the following
conditions:

a)  CCC  will  not release any financial or other material information about the
Corporation  without  prior  written  consent  and  approval of the Corporation.

b)  CCC  will not conduct any meetings with financial analysts without informing
the  Corporation  in  writing  in  advance  of  the  proposed  meeting.

c)  After  notice  to  CCC  by the Corporation of a filing for a proposed public
offering  of  securities, and during any period of restriction on publicity, CCC
shall  not  engage  in  any public relations efforts not in the normal course of
business  without  the  prior  written  approval  of  legal  counsel  for  the
Corporation.

d)  CCC  will  indemnify  the  Corporation  from all claims, liability, costs or
other  expenses  (including  reasonable  attorneys'  fees)  incurred  by  the
Corporation as a result of any inaccurate information concerning the Corporation
released by CCC, unless such information was provided to CCC by the Corporation,
or  as  a result of any breach by CCC of any of the terms and conditions of this
agreement.

e)  CCC  acknowledges  and  confirms  that  in  providing  the  services  to the
Corporation  hereunder,  it  will  at  all  times  act  in  accordance  with all
applicable  laws.

8.  ADDITIONAL  OBLIGATIONS  OF  THE  COMPANY.  The  Corporation agrees that, in
connection  with  this  agreement,  it  will  indemnify  CCC  from  all  claims,
liability,  costs  or  other  expenses incurred (including reasonable attorneys'
fees)  incurred  by  CCC  as  a  result of any false or intentionally misleading
information concerning the Corporation provided by the Corporation or any of its
officers or directors to CCC, or as a result of any breach by the Corporation of
any  of  the  terms  and  conditions of this agreement. If, in the Corporation's
judgment,  any material non-public information concerning the Corporation cannot
be revealed, it will advise CCC in writing that a quiet period is in effect.

9.  INDEPENDENT  CONTRACTOR.  CCC  is  an independent contractor responsible for
compensation  of  its  agents,  employees  and  representatives.

10.  ASSIGNMENT.  The rights and obligations of each party to this Agreement may
not  be  assigned  without  the  prior written consent of the other party, which
shall  not  be  unreasonably  withheld.

11.  ENTIRE  AGREEMENT.  This  letter  Agreement between the Corporation and CCC
contains  the  entire agreement between them. This Agreement may not be modified
or  extended  except  in  writing  and  signed  by  the  Corporation  and  CCC.

12.  GOVERNING  LAW.  This  Agreement  shall  be  governed  by  and construed in
accordance  with  the  laws  of  the  Province  of  Ontario,  Canada.

13.  ARBITRATION. ANY DISPUTE BASED UPON OR ARISING OUT OF THIS LETTER AGREEMENT
SHALL  BE  SUBJECT  TO  BINDING ARBITRATION TO BE HELD IN TORONTO, ONTARIO.  THE
ARBITRATOR'S  AWARD  SHALL  BE  FINAL  AND  BINDING,  AND  MAY BE ENTERED IN ANY
COMPETENT COURT. AS A PRACTICAL MATTER, BY AGREEING TO ARBITRATE ALL PARTIES ARE
WAIVING  JURY  TRIAL.

                                     Page 3
<PAGE>
14.  ATTORNEY'S  FEES.  The  prevailing  party  in any arbitration or litigation
arising out of or relating to this letter agreement shall be entitled to recover
all  attorney's  fees  and  all costs (whether or not such costs are recoverable
pursuant  to  the  laws  governing the Province of Ontario as may be incurred in
connection  with  either obtaining or collecting any judgment and/or arbitration
award, in addition to any other relief to which that party may be entitled.

15.  REGULATORY  AUTHORITY.  The  Corporation's obligations under this Agreement
are subject to the prior receipt of all necessary regulatory approvals.

Please  sign  this letter agreement in the space provided below to indicate your
agreement  with  the  terms  stated  in  this  letter.

Sincerely,

CURRENT CAPITAL CORP.

/s/ John Robinson
-----------------------------
John Robinson
Director

AGREED AND ACCEPTED

DERMISONICS, INC.

/s/ Bruce Haglund
-----------------------------
Bruce Haglund
PresidentChairman

                                     Page 4
<PAGE>FORM OF WARRANT
                                 ---------------

NEITHER  THIS  WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE
HAVE  BEEN  REGISTERED  WITH  THE  SECURITIES  AND  EXCHANGE  COMMISSION  OR THE
SECURITIES  COMMISSION  OF  ANY  STATE  IN  RELIANCE  UPON  AN  EXEMPTION  FROM
REGISTRATION  UNDER  THE  SECURITIES  ACT  OF  1933, AS AMENDED (THE "SECURITIES
ACT"),  AND,  ACCORDINGLY,  MAY  NOT  BE  OFFERED  OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE  REGISTRATION  STATEMENT  UNDER  THE  SECURITIES ACT OR PURSUANT TO AN
AVAILABLE  EXEMPTION  FROM  THE  REGISTRATION  REQUIREMENTS  THEREUNDER  AND  IN
COMPLIANCE WITH APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.

                      -----------------------------------

                                DERMISONICS, INC.
                                -----------------

                          COMMON STOCK PURCHASE WARRANT

Dated:  October 20, 2004

     DERMISONICS,  INC.,  a corporation organized and existing under the laws of
the  State of Nevada (the "Company"), hereby certifies that, for value received,
CURRENT  CAPITAL  CORP.  or  its registered assigns (the "Holder"), is entitled,
subject to the terms set forth below, to purchase from the Company up to a total
of  200,000  shares  of  Common  Stock,  $0.01  par value per share (the "Common
Stock"), of the Company (each such share, a "Warrant Share" and all such shares,
the  "Warrant  Shares")  at  an  exercise price equal to $2.00 per Warrant Share
(hereinafter  this common stock purchase warrant is referred to as the "Warrant"
or  the  "Warrants"). The Warrants shall be exercisable from the date hereof and
through  and including September 30, 2006 (the "Expiration Date").  This Warrant
is subject to the following additional terms and conditions:

     1.     Registration  of  Warrant.  The Company shall register this Warrant,
            -------------------------
upon  records  to  be  maintained  by the Company for that purpose (the "Warrant
Register"),  in  the  name  of  the record Holder hereof from time to time.  The
Company may deem and treat the registered Holder of this Warrant as the absolute
owner  hereof  for the purpose of any exercise hereof or any distribution to the
Holder,  and  for  all  other purposes, and the Company shall not be affected by
notice  to  the  contrary.

     1.     Registration  of  Transfers  and  Exchanges.
            -------------------------------------------

          (a)     The Company shall register the transfer of any portion of this
Warrant  in  the Warrant Register, upon surrender of this Warrant, with the Form
of  Assignment  attached hereto duly completed and signed, to the Company at its
address  for  notice

                                     Page 1
<PAGE>
specified  in  Section  10  along  with  an  opinion  of  counsel  to the Holder
reasonably  acceptable  to  the  Company  that such transfer may be made without
compliance  with  Federal and state securities laws.  Upon any such registration
or  transfer,  a new warrant to purchase Common Stock, in substantially the form
of  this Warrant (any such new warrant, a "New Warrant"), evidencing the portion
of  this  Warrant  so  transferred  shall  be issued to the transferee and a New
Warrant  evidencing the remaining portion of this Warrant not so transferred, if
any,  shall  be  issued  to  the transferring Holder.  The acceptance of the New
Warrant  by  the  transferee  thereof  shall  be  deemed  the acceptance of such
transferee of all of the rights and obligations of a holder of a Warrant.

          (b)     This Warrant is exchangeable, upon the surrender hereof by the
Holder  to  the  office  of  the  Company at its address for notice specified in
Section  10  for one or more New Warrants, evidencing in the aggregate the right
to  purchase the number of Warrant Shares which may then be purchased hereunder.
Any such New Warrant will be dated the date of such exchange.

     2.     Duration,  Exercise  and  Redemption  of  Warrants.
            --------------------------------------------------

          (a)     This  Warrant shall be exercisable by the registered Holder on
any business day before 5:00 P.M., New York City time, at any time and from time
to time on or after the date hereof, in accordance with the Vesting Schedule, to
and  including  the  Expiration  Date.  At  5:00 P.M., New York City time on the
Expiration  Date,  the portion of this Warrant not exercised prior thereto shall
be  and  become  void  and of no value.  This Warrant shall be redeemable by the
Company  as  provided  in  Section  4,  below.

          (b)     Subject  to  Sections  2(b)  and  6,  upon  surrender  of this
Warrant,  with  the  Form of Election to Purchase attached hereto duly completed
and signed, to the Company at its address for notice set forth in Section 10 and
upon  payment  of  the Exercise Price multiplied by the number of Warrant Shares
that  the  Holder  intends  to purchase hereunder, in lawful money of the United
States of America, in cash or by certified or official bank check or checks, all
as  specified  by  the  Holder  in the Form of Election to Purchase, the Company
shall promptly (but in no event later than three business days after the Date of
Exercise  (as  defined  herein))  issue  or  cause  to be issued and cause to be
delivered  to  or upon the written order of the Holder and in such name or names
as  the Holder may designate, a certificate for the Warrant Shares issuable upon
such exercise.  Any person so designated by the Holder to receive Warrant Shares
shall  be  deemed to have become a holder of record of such Warrant Shares as of
the  Date  of  Exercise of this Warrant.  A "Date of Exercise" means the date on
which  the  Company shall have received (i) this Warrant (or any New Warrant, as
applicable),  with the Form of Election to Purchase attached hereto (or attached
to  such  New Warrant) appropriately completed and duly signed, and (ii) payment
of  the  Exercise  Price  for  the  number of Warrant Shares so indicated by the
holder  hereof  to  be  purchased.

                                     Page 2
<PAGE>
          (c)     This  Warrant shall be exercisable, either in its entirety or,
from  time to time, for a portion of the number of Warrant Shares.  If less than
all  of  the  Warrant  Shares  which  may  be  purchased  under this Warrant are
exercised  at  any  time,  the Company shall issue or cause to be issued, at its
expense,  a New Warrant evidencing the right to purchase the remaining number of
Warrant  Shares  for  which  no  exercise  has  been  evidenced by this Warrant.

     3.     Redemption  of Warrant.  The Warrants may be redeemed by the Company
            ----------------------
at  any  time  on  30  day's  written  notice  to the Holder at the last address
therefor  as  it  shall appear upon the Warrant Register at a price of $0.01 per
Warrant  commencing  immediately  after  the Registration Date provided that the
average  closing  bid  price  per  share of Common Stock for the 30 trading days
ending  five  days prior to the date of the redemption notice of the Warrants is
at  least  $4.00  per  share.

     4.     Payment  of Taxes.  The Company will pay all documentary stamp taxes
            -----------------
attributable  to  the  issuance  of  Warrant  Shares  upon  the exercise of this
Warrant;  provided,  however,  that the Company shall not be required to pay any
tax which may be payable in respect of any transfer involved in the registration
of  any certificates for Warrant Shares or Warrants in a name other than that of
the Holder, and the Company shall not be required to issue or cause to be issued
or  deliver  or cause to be delivered the certificates for Warrant Shares unless
or  until  the person or persons requesting the issuance thereof shall have paid
to  the  Company  the  amount  of  such  tax  or  shall  have established to the
satisfaction  of  the  Company that such tax has been paid.  The Holder shall be
responsible for all other tax liability that may arise as a result of holding or
transferring this Warrant or receiving Warrant Shares upon exercise hereof.

     5.     Replacement  of Warrant.  If this Warrant is mutilated, lost, stolen
            -----------------------
or  destroyed,  the  Company  shall  issue or cause to be issued in exchange and
substitution  for  and  upon cancellation hereof, or in lieu of and substitution
for  this  Warrant,  a New Warrant, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction and indemnity, if
reasonably  satisfactory  to  it.  Applicants  for  a  New  Warrant  under  such
circumstances  shall  also  comply  with  such  other reasonable regulations and
procedures and pay such other reasonable charges as the Company may prescribe.

     6.     Reservation  of  Warrant Shares.  The Company covenants that it will
            -------------------------------
at  all  times reserve and keep available out of the aggregate of its authorized
but  unissued  Common  Stock,  solely  for  the  purpose of enabling it to issue
Warrant  Shares  upon exercise of this Warrant as herein provided, the number of
Warrant Shares which are then issuable and deliverable upon the exercise of this
entire  Warrant,  free  from  preemptive  rights  or any other actual contingent
purchase  rights  of  persons  other  than  the Holders (taking into account the
adjustments  and  restrictions  of  Section  8).  The Company covenants that all
Warrant  Shares  that  shall be so issuable and deliverable shall, upon issuance
and  the

                                     Page 3
<PAGE>
payment of the applicable Exercise Price in accordance with the terms hereof, be
duly and validly authorized, issued and fully paid and nonassessable.

     7.     Certain  Adjustments.  The  Exercise  Price  and  number  of Warrant
            --------------------
Shares  issuable  upon  exercise  of this Warrant are subject to adjustment from
time  to  time as set forth in this Section 8.  Upon each such adjustment of the
Exercise  Price pursuant to this Section 8, the Holder shall thereafter prior to
the  Expiration  Date  be  entitled to purchase, at the Exercise Price resulting
from  such  adjustment, the number of Warrant Shares obtained by multiplying the
Exercise  Price  in effect immediately prior to such adjustment by the number of
Warrant  Shares issuable upon exercise of this Warrant immediately prior to such
adjustment and dividing the product thereof by the Exercise Price resulting from
such  adjustment.

          (a)     If the Company, at any time while this Warrant is outstanding,
(i) shall pay a stock dividend or otherwise make a distribution or distributions
on  shares  of  its  Common  Stock  (as  defined below) or on any other class of
capital stock (and not the Common Stock) payable in shares of Common Stock, (ii)
subdivide  outstanding shares of Common Stock into a larger number of shares, or
(iii)  combine  outstanding  shares  of  Common  Stock  into a smaller number of
shares,  the  Exercise  Price  shall  be  multiplied  by a fraction of which the
numerator  shall  be  the  number  of shares of Common Stock (excluding treasury
shares, if any) outstanding before such event and of which the denominator shall
be  the  number  of  shares  of Common Stock (excluding treasury shares, if any)
outstanding  after  such  event.  Any  adjustment  made pursuant to this Section
shall  become  effective immediately after the record date for the determination
of  stockholders  entitled  to  receive  such dividend or distribution and shall
become  effective  immediately  after  the  effective  date  in  the  case  of a
subdivision  or  combination,  and  shall  apply  to successive subdivisions and
combinations.

          (b)     In  case  of  any  reclassification  of  the Common Stock, any
consolidation  or merger of the Company with or into another person, the sale or
transfer  of  all or substantially all of the assets of the Company in which the
consideration  therefor  is  equity  or  equity  equivalent  securities  or  any
compulsory  share  exchange pursuant to which the Common Stock is converted into
other securities or property, then the Holder shall have the right thereafter to
exercise  this  Warrant  only  into the shares of stock and other securities and
property  receivable  upon  or  deemed  to  be  held  by holders of Common Stock
following  such reclassification, consolidation, merger, sale, transfer or share
exchange,  and  the  Holder  shall  be  entitled upon such event to receive such
amount  of  securities or property of the Company's business combination partner
equal  to  the  amount of Warrant Shares such Holder would have been entitled to
had  such  Holder  exercised  this  Warrant  immediately  prior  to  such
reclassification,  consolidation, merger, sale, transfer or share exchange.  The
terms  of any such consolidation, merger, sale, transfer or share exchange shall
include  such terms so as to continue to give to the Holder the right to receive
the  securities  or  property  set  forth in this Section 8(b) upon any exercise
following  any  such  reclassification, consolidation, merger, sale, transfer or
share  exchange.

                                     Page 4
<PAGE>
          (c)      If  the  Company,  at  any  time  while  this  Warrant  is
outstanding, shall distribute to all holders of Common Stock (and not to holders
of  this  Warrant) evidences of its indebtedness or assets or rights or warrants
to  subscribe  for  or  purchase  any  security  (excluding those referred to in
Sections  8(a), (b) and (d)), then in each such case the Exercise Price shall be
determined  by multiplying the Exercise Price in effect immediately prior to the
record  date  fixed  for  determination of stockholders entitled to receive such
distribution  by a fraction of which the denominator shall be the Exercise Price
determined  as  of  the  record date mentioned above, and of which the numerator
shall be such Exercise Price on such record date less the then fair market value
at such record date of the portion of such assets or evidence of indebtedness so
distributed applicable to one outstanding share of Common Stock as determined by
a  nationally  recognized  or  major regional investment banking firm or firm of
independent  certified  public accountants of recognized standing (which, in all
events,  may be the firm that regularly examines the financial statements of the
Company)  (an  "Appraiser")  mutually selected in good faith by the holders of a
majority  in  interest  of  the  Warrants then outstanding and the Company.  Any
determination  made  by  the  Appraiser  shall  be  final.

          (d)     If, at any time while this Warrant is outstanding, the Company
shall  issue  or  cause  to be issued rights or warrants to acquire or otherwise
sell  or  distribute shares of Common Stock to all holders of Common Stock for a
consideration  per  share  less  than  the  Exercise Price then in effect, then,
forthwith  upon  such  issue or sale, the Exercise Price shall be reduced to the
price  (calculated  to  the  nearest  cent) determined by dividing (i) an amount
equal  to  the  sum  of  (A)  the  number  of shares of Common Stock outstanding
immediately  prior  to  such issue or sale multiplied by the Exercise Price, and
(B)  the  consideration, if any, received or receivable by the Company upon such
issue  or  sale  by  (ii) the total number of shares of Common Stock outstanding
immediately  after  such  issue  or  sale.

          (e)     For  the  purposes  of  this  Section 8, the following clauses
shall  also  be  applicable:

               (i)  Record Date.  In case the Company shall take a record of the
                    -----------
holders  of  its Common Stock for the purpose of entitling the holders of Common
Stock (A) to receive a dividend or other distribution payable in Common Stock or
in securities convertible or exchangeable into shares of Common Stock, or (B) to
subscribe for or purchase Common Stock or securities convertible or exchangeable
into  shares  of  Common  Stock, then such record date shall be deemed to be the
date  of  the  issue  or  sale of the shares of Common Stock deemed to have been
issued or sold upon the declaration of such dividend or the making of such other
distribution  or  the  date  of  the  granting  of such right of subscription or
purchase,  as  the  case  may  be.

               (ii)  Treasury  Shares.  The  number  of  shares  of Common Stock
                     ----------------
outstanding  at  any given time shall not include shares owned or held by or for
the  account

                                     Page 5
<PAGE>
of  the  Company,  and the disposition of any such shares shall be considered an
issue  or  sale  of  Common  Stock.

          (f)     All  calculations  under  this  Section 8 shall be made to the
nearest cent or the nearest 1/100th of a share, as the case may be.

          (g)     If:

                  (i)    the  Company  shall  declare  a  dividend (or any other
                         distribution)  on  its  Common  Stock;  or

                  (ii)   the  Company  shall declare a special nonrecurring cash
                         dividend  on  or  a  redemption of its Common Stock; or

                  (iii)  the  Company  shall  authorize  the  granting  to  all
                         holders  of  the  Common  Stock  rights  or warrants to
                         subscribe  for  or purchase any shares of capital stock
                         of  any  class  or  of  any  rights;  or

                  (iv)   the  approval  of any stockholders of the Company shall
                         be  required in connection with any reclassification of
                         the  Common  Stock of the Company, any consolidation or
                         merger  to  which  the  Company is a party, any sale or
                         transfer  of  all or substantially all of the assets of
                         the  Company,  or any compulsory share exchange whereby
                         the  Common  Stock  is converted into other securities,
                         cash  or  property;  or

                  (v)    the  Company shall authorize the voluntary dissolution,
                         liquidation  or  winding  up  of  the  affairs  of  the
                         Company;

then the Company shall cause to be mailed to each Holder at their last addresses
as  they shall appear upon the Warrant Register, at least 30 calendar days prior
to  the  applicable  record  or  effective  date hereinafter specified, a notice
stating  (x)  the  date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to
be  taken,  the  date  as  of  which the holders of Common Stock of record to be
entitled  to such dividend, distributions, redemption, rights or warrants are to
be  determined  or  (y)  the date on which such reclassification, consolidation,
merger,  sale,  transfer  or  share  exchange is expected to become effective or
close,  and  the date as of which it is expected that holders of Common Stock of
record  shall  be  entitled  to  exchange  their  shares  of  Common  Stock  for
securities,  cash  or  other  property  deliverable  upon such reclassification,
consolidation,  merger, sale, transfer, share exchange, dissolution, liquidation
or  winding  up;  provided, however, that the failure to mail such notice or any
                  --------  -------
defect  therein  or  in the mailing thereof shall not affect the validity of the
corporate action required to be specified in such notice.

     8.     Payment  of Exercise Price.  The Holder may exercise this Warrant by
            --------------------------
tendering  to  the Company cash or certified or official bank check or checks in
an  amount  calculated

                                     Page 6
<PAGE>
by  multiplying the Exercise Price per share by the number of Warrant Shares the
Holder  desires  to  purchase.

     10.     Fractional  Shares.  The  Company shall not be required to issue or
             ------------------
cause  to  be  issued fractional Warrant Shares on the exercise of this Warrant.
The  number  of full Warrant Shares which shall be issuable upon the exercise of
this  Warrant  shall be computed on the basis of the aggregate number of Warrant
Shares purchasable on exercise of this Warrant so presented.  If any fraction of
a  Warrant Share would, except for the provisions of this Section 9, be issuable
on  the  exercise  of this Warrant, the Company shall, at its option, (i) pay an
amount  in  cash equal to the Exercise Price multiplied by such fraction or (ii)
round the number of Warrant Shares issuable, up to the next whole number.

     11.     Notices.  Any and all notices or other communications or deliveries
             -------
hereunder  shall  be  in  writing and shall be deemed given and effective on the
earliest  of  (i)  the  date of transmission, if such notice or communication is
delivered  via  facsimile  at  the  facsimile telephone number specified in this
Section,  (ii)  the  business  day  following  the  date  of mailing, if sent by
internationally  recognized  overnight  courier  service,  or  (iii) upon actual
receipt by the party to whom such notice is required to be given.  The addresses
for  such  communications  shall  be:

          If to the Company:  DERMISONICS, INC.
                              c/o Bruce H. Haglund
                              2 Park Plaza, Suite 450
                              Irvine, California  92164
                              Facsimile Number: (949) 733-1188

          If to the Holder:   CURRENT CAPITAL CORP.
                              Suite 200, 47 Avenue Rd.
                              Toronto, Ontario M5R 2G3, Canada
                              Facsimile Number: (416) 361-6228

Either party may change the address and facsimile number to which notices are to
be  sent by delivering notice to the other party in accordance with this Section
11.

12.     Warrant  Agent.
        --------------

          (a)     The  Company  shall serve as warrant agent under this Warrant.
Upon 30 days' notice to the Holder, the Company may appoint a new warrant agent.

          (b)     Any  corporation  into  which  the  Company or any new warrant
agent may be merged or any corporation resulting from any consolidation to which
the  Company  or  any  new  warrant agent shall be a party or any corporation to
which  the  Company  or any new warrant agent transfers substantially all of its
corporate  trust  or shareholders services business shall be a successor warrant
agent  under  this  Warrant without any further act.  Any such successor warrant
agent  shall  promptly  cause  notice  of  its  succession  as  warrant

                                     Page 7
<PAGE>
agent  to  be mailed (by first class mail, postage prepaid) to the Holder at the
Holder's  last  address  as  shown  on  the  Warrant  Register.

     13.     Miscellaneous.
             -------------

          (a)     This  Warrant  shall be binding on and inure to the benefit of
the  parties hereto and their respective successors and permitted assigns.  This
Warrant  may  be  amended  only in writing signed by the Company and the Holder.

          (b)     Subject to Section 12(a), above, nothing in this Warrant shall
be construed to give to any person or corporation other than the Company and the
Holder  any  legal  or equitable right, remedy or cause under this Warrant; this
Warrant  shall  be  for  the  sole  and exclusive benefit of the Company and the
Holder.

          (c)     This  Warrant  shall be governed by and construed and enforced
in  accordance  with  the internal laws of the State of Nevada without regard to
the  principles  of  conflicts  of  law  thereof.

          (d)     The  headings  herein  are  for  convenience  only,  do  not
constitute a part of this Warrant and shall not be deemed to limit or affect any
of  the  provisions  hereof.

          (e)     In  case  any  one  or  more of the provisions of this Warrant
shall  be  invalid  or  unenforceable  in  any  respect,  the  validity  and
enforceability  of  the remaining terms and provisions of this Warrant shall not
in  any way be affected or impaired thereby and the parties will attempt in good
faith  to  agree  upon  a  valid  and  enforceable  provision  which  shall be a
commercially  reasonable  substitute  therefor,  and  upon  so  agreeing,  shall
incorporate  such  substitute  provision  in  this  Warrant.

     IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed
by  its  authorized  officer  as  of  the  date  first  indicated  above.

                              DERMISONICS, INC.

                              By:
                                 ------------------------------

                              Name:
                                   ----------------------------

                              Title:
                                    ---------------------------

                                     Page 8
<PAGE>
                          FORM OF ELECTION TO PURCHASE

         (To be executed by the Holder to exercise the right to purchase
               shares of Common Stock under the foregoing Warrant)

To:  DERMISONICS,  INC.:

     In  accordance  with  the  Warrant  enclosed  with this Form of Election to
Purchase,  the  undersigned  hereby irrevocably elects to purchase [___________]
shares  of  Common  Stock  ("Common  Stock"),  $0.01  par  value  per  share, of
DERMISONICS,  INC.  and  encloses  herewith  $________  in  cash or certified or
official bank check or checks, which sum represents the aggregate Exercise Price
(as  defined  in  the Warrant) for the number of shares of Common Stock to which
this  Form  of  Election to Purchase relates, together with any applicable taxes
payable  by  the  undersigned  pursuant  to  the  Warrant.

     The  undersigned  requests that certificates for the shares of Common Stock
issuable upon this exercise be issued in the name of

Print name and address:
                                  ----------------------------------

                                  ----------------------------------

                                  ----------------------------------

                                  ----------------------------------

Print social security or
tax identification number:
                                  ----------------------------------

     If  the  number of shares of Common Stock issuable upon this exercise shall
not  be  all  of the shares of Common Stock which the undersigned is entitled to
purchase  in accordance with the enclosed Warrant, the undersigned requests that
a  New  Warrant (as defined in the Warrant) evidencing the right to purchase the
shares of Common Stock not issuable pursuant to the exercise evidenced hereby be
issued  in  the  name  of  and  delivered  to:

Print name and address:
                                  ----------------------------------

                                  ----------------------------------

<PAGE>
                                  ----------------------------------

                                  ----------------------------------

<PAGE>
Dated:                         Name  of  Holder:
      -----------                                  -----------------------------
----------
                         Signature:
                                              ----------------------------------

                         By  (if  entity):
                                              ----------------------------------

                         Name  (if  entity):
                                              ----------------------------------

                         Title  (if  entity):
                                              ----------------------------------

                         (Signature  must  conform  in  all  respects to name of
                         holder as specified on the face of the Warrant)

<PAGE>
           [To be completed and signed only upon transfer of Warrant]

     FOR  VALUE  RECEIVED,  the  undersigned hereby sells, assigns and transfers
Unto____________________________________________________________________________
the  right  represented  by  the  within  Warrant  to  purchase ________________
shares  of Common Stock of DERMISONICS, INC. to which the within Warrant relates
and  appoints the Secretary of DERMISONICS, INC. attorney to transfer said right
on  the  books  of  DERMISONICS,  INC.  with  full  power of substitution in the
premises.

Dated:                   Name  of  Holder:
      ---------                               ----------------------------------

                         Signature:
                                              ----------------------------------

                         By  (if  entity):
                                              ----------------------------------

                         Name  (if  entity):
                                              ----------------------------------

                         Title  (if  entity):
                                              ----------------------------------

                         (Signature  must  conform  in  all  respects to name of
                         holder as specified on the face of the Warrant)

Name and Address of Transferee:
                                    ----------------------------------

                                         ----------------------------------

                                         ----------------------------------

In the presence of:

---------------------------------------

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00073-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00073-of-00352.parquet"}]]